Literature DB >> 8234287

Differential expression of four members of the POU family of proteins in activated and phorbol 12-myristate 13-acetate-treated Jurkat T cells.

A K Bhargava1, Z Li, S M Weissman.   

Abstract

The POU family of proteins binds specifically to octamer DNA motifs present in the promoters of several genes and regulates their expression. We identified the presence of four members of the POU family of proteins, Oct-1, Oct-2, Oct-T1, and Oct-T2, in the human T-cell line Jurkat. To obtain insight into the physiological role played by these proteins in T cells, we studied the time course of expression of these genes in resting, activated, and phorbol 12-myristate 13-acetate (PMA)-treated cells. The expression of the gene encoding Oct-1 (now assigned the name OTF1 for octamer-binding transcription factor 1) remained unchanged and the levels of Oct-T2 mRNA decreased with increasing time of incubation to undetectable amounts in all three states of T-cell growth. The levels of Oct-2 mRNA and protein were increased in activated cells, were increased to a lesser extent in the PMA-treated cells, and were undetectable in resting cells. The levels of the Oct-T1 transcripts increased dramatically in PMA-treated cells but not in resting or activated cells. Sequence analysis of the Oct-T1 cDNA showed an open reading frame coding for a POU domain-containing protein of 42.7 kDa. Transient transfection of the gene encoding Oct-T1 decreased the activity of the interleukin 2 gene promoter in activated Jurkat cells. Further, there is evidence for an additional octamer-binding protein, Oct-T3, in Jurkat T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234287      PMCID: PMC47754          DOI: 10.1073/pnas.90.21.10260

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

4.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

Authors:  M Fried; D M Crothers
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

5.  Structure of the human interleukin 2 gene.

Authors:  T Fujita; C Takaoka; H Matsui; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

Authors:  K Zinn; D DiMaio; T Maniatis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

7.  Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes.

Authors:  K S Ullman; J P Northrop; A Admon; G R Crabtree
Journal:  Genes Dev       Date:  1993-02       Impact factor: 11.361

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes.

Authors:  R Wiskocil; A Weiss; J Imboden; R Kamin-Lewis; J Stobo
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor.

Authors:  D B Durand; M R Bush; J G Morgan; A Weiss; G R Crabtree
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  7 in total

1.  Oct-1 [corrected] and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases.

Authors:  S J Grenfell; D S Latchman; N S Thomas
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Analysis of differential gene expression by display of 3' end restriction fragments of cDNAs.

Authors:  Y Prashar; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

3.  Multiplex selection technique (MuST): an approach to clone transcription factor binding sites.

Authors:  G N Nallur; K Prakash; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

4.  Jun kinase phosphorylates and regulates the DNA binding activity of an octamer binding protein, T-cell factor beta1.

Authors:  S Kasibhatla; P Tailor; N Bonefoy-Berard; T Mustelin; A Altman; A Fotedar
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB.

Authors:  Kerstin Mueller; Jasmin Quandt; Ralf B Marienfeld; Petra Weihrich; Katja Fiedler; Melina Claussnitzer; Helmut Laumen; Martin Vaeth; Friederike Berberich-Siebelt; Edgar Serfling; Thomas Wirth; Cornelia Brunner
Journal:  Nucleic Acids Res       Date:  2013-01-04       Impact factor: 16.971

6.  Essential but partially redundant roles for POU4F1/Brn-3a and POU4F2/Brn-3b transcription factors in the developing heart.

Authors:  Lauren J Maskell; Kashif Qamar; Aram A Babakr; Thomas A Hawkins; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2017-06-08       Impact factor: 8.469

Review 7.  Linking metabolic dysfunction with cardiovascular diseases: Brn-3b/POU4F2 transcription factor in cardiometabolic tissues in health and disease.

Authors:  Vishwanie S Budhram-Mahadeo; Matthew R Solomons; Eeshan A O Mahadeo-Heads
Journal:  Cell Death Dis       Date:  2021-03-12       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.